Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis.

Johanna Nagel, Göran Jönsson, Jan-Åke Nilsson, C Manuswin, Martin Englund, Tore Saxne, Meliha C Kapetanovic

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis.'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology